Position
Vice President
Company
TuHURA Biosciences
Description
TuHURA Biosciences, Inc. has appointed Bertrand Le Bourdonnec, PhD, as Executive Vice President, Head of Drug Discovery, Early Development, and Program Management. Dr Le Bourdonnec brings extensive experience in drug discovery and clinical development, particularly in oncology and pain management.
Quick answer
TuHURA Appoints Bertrand Le Bourdonnec as Executive Vice President (April 7, 2025). TuHURA Biosciences is based in Tampa, Florida, United States.
- Who is the new Vice President at TuHURA Biosciences?
- TuHURA Biosciences named Bertrand Le Bourdonnec Vice President, announced April 7, 2025.
- What did TuHURA Biosciences announce on April 7, 2025?
- TuHURA Biosciences, Inc. has appointed Bertrand Le Bourdonnec, PhD, as Executive Vice President, Head of Drug Discovery, Early Development, and Program Management. Dr Le Bourdonnec brings extensive experience in drug discovery and clinical development, particularly in oncology and pain management.
- What does TuHURA Biosciences do?
- Morphogenesis, Inc. Announces Corporate Rebranding to TuHURA Biosciences, Inc. TuHURA Biosciences, Inc. is a Phase 3 registration-stage immuno-oncology company developing novel technologies to overcome resistance to...
- Where is TuHURA Biosciences based?
- TuHURA Biosciences is based in Tampa, Florida, United States.
- Which similar companies made leadership changes around the same time?
- Geneoscopy (April 2, 2025), Inhibikase Therapeutics (April 14, 2025), Madrigal Pharmaceuticals (April 16, 2025) and Werewolf Therapeutics (April 17, 2025) also announced leadership changes within 45 days of TuHURA Biosciences.
Source: Fundz verified event record.
Other recent leadership changes in Healthcare and Therapeutics
Executive moves at companies in the same sectors within 45 days, from Fundz verified event records.
- Geneoscopy Appoints Amit Bhalla as Chief Financial Officer (April 2, 2025)
- Inhibikase Therapeutics Appoints David McIntyre as Chief Financial Officer (April 14, 2025)
- Madrigal Pharmaceuticals Appoints David Soergel as Chief Medical Officer (April 16, 2025)
- Werewolf Therapeutics Appoints Steven Bloom as Chief Business Officer (April 17, 2025)
- Verrica Pharmaceuticals Appoints Noah L. Rosenberg, M.D., as Chief Medical Officer (March 26, 2025)
- AEON Biopharma Appoints Rob Bancroft as Chief Executive Officer (April 22, 2025)
Who to call at TuHURA Biosciences, and when
A new leader at TuHURA Biosciences brings new priorities and often new vendors. The first weeks are when they listen.
- An alert the day TuHURA Biosciences raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at TuHURA Biosciences, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at TuHURA Biosciences. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment TuHURA Biosciences changes its leadership, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
TuHURA Biosciences changed its leadership. Fundz had it the day it was filed, with the decision-maker at the company attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.